SCHEMBL4787333

SCHEMBL4787333

C#CNC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3070736 0.73
SCHEMBL335688 0.69
SCHEMBL7533725 0.67 ALDH1A1 (0.31)
Water SCHEMBL2152723 0.67
SCHEMBL130233 0.67
SCHEMBL375468 0.67
SCHEMBL15222 0.67
SCHEMBL13621673 0.67
SCHEMBL9517518 0.65
Hydrochloric Acid SCHEMBL2152574 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3570897-B1 RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES THERAPHARM GMBH (CH) 2023-10-04 EP claimed
EP-3749670-B1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA UNIV PALACKEHO (CZ) 2021-10-06 EP claimed
EP-2111135-B1 ORAL CARE IMPLEMENT HAVING FLUID DELIVERY SYSTEM COLGATE PALMOLIVE CO (US) 2018-07-04 EP claimed
EP-2476691-B1 METHOD FOR MANUFACTURING A LIPIDIC PEPTIDE COMPOUND NISSAN CHEMICAL IND LTD (JP) 2018-01-03 EP claimed
EP-2117376-B1 ORAL CARE IMPLEMENT HOUSING AN ORAL CARE AGENT COLGATE PALMOLIVE CO (US) 2017-11-15 EP claimed
EP-2825208-B1 P75NTR NEUROTROPHIN BINDING PROTEIN FOR THERAPEUTIC USE LEVICEPT LTD (GB) 2017-05-17 EP claimed
EP-1903905-B1 ORAL CARE IMPLEMENT HAVING RESERVOIR FOR DISPENSING ACTIVE AGENT COLGATE PALMOLIVE CO (US) 2016-12-28 EP claimed
EP-2742039-B1 COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE HOFFMANN LA ROCHE (CH) 2015-09-16 EP claimed
EP-2172475-B1 LIPID PEPTIDE FOR USE AS HYDROGEL NISSAN CHEMICAL IND LTD (JP) 2015-06-03 EP claimed
EP-2493863-B1 PHENOXY-SUBSTITUTED PYRIMIDINES AS OPIOID RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-02-25 EP claimed
EP-2328510-B1 ORAL CARE IMPLEMENT WITH CAVITATION SYSTEM COLGATE PALMOLIVE CO (US) 2014-10-15 EP claimed
EP-1962913-B1 RADIOIMMUNOCONJUGATE FOR HUMAN CD66 FOR THE TREATMENT OF MULTIPLE MYELOMA THERAPHARM GMBH (CH) 2013-12-04 EP claimed
WO-2008107321-A1 HETEROCYCLIC COMPOUNDS USED AS ANTI-NEOPLASIC AGENTS OR CELL PROLIFERATION INHIBITORS CEREP (FR) 2008-09-12 WO claimed
EP-1202975-B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRAZINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORP (US) 2005-04-06 EP claimed
EP-1268463-B1 POLYCYCLIC ARYL AND HETEROARYL SUBSTITUTED 4-PYRONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORP (US) 2005-02-16 EP claimed
EP-1144403-B1 SUBSTITUTED PYRAZOLES AS P38 KINASE INHIBITORS SEARLE LLC (US) 2004-10-06 EP claimed
EP-0805674-B1 SKIN AND HAIR COSMETIC COMPOSITIONS KAO CORP (JP) 2003-03-12 EP claimed
EP-0842180-B1 PENAM SULFONES AS BETA-LACTAMASE INHIBITORS NAEJA PHARMACEUTICAL INC (CA) 2003-01-22 EP claimed
EP-0102034-B1 SPIRO(2H-1,4-BENZODIOXEPIN-3(5H)4'-PIPERIDINE AND 3'-PYRROLIDINO) COMPOUNDS, A PROCESS FOR PREPARING THE SAME AND THEIR USE AS MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-04-20 EP claimed
EP-0039903-B1 8-SUBSTITUTED PYRROLIZIDINES AND QUATERNARY AMMONIUM SALTS THEREOF SUNTORY KABUSHIKI KAISHA (JP) 1986-04-09 EP claimed